Governor Tom Wolf announced that West Pharmaceutical Services, Inc. (West), a leading global manufacturer in the design and production of injectable drug delivery and containment systems, is creating 225 new full-time jobs in as part of its expansion project in Jersey Shore, Lycoming County.
“West clearly recognizes the benefits of doing business in Pennsylvania, and I’m glad they continue to grow right here in the Commonwealth,” Governor Wolf said. “Our strong manufacturing base has given us a competitive advantage over other states for this expansion project. It’s always great to see local businesses — especially a global manufacturer like West — continue to thrive and succeed in Pennsylvania.
In response to growing demand for its products and services, the company is expanding its factory at 347 Oliver Street, Jersey Shore by increasing existing production capacity and providing additional floor space to accommodate future growth.
West’s expansion requires the company to also increase its back office, administrative and research and development services at its headquarters in Exton, Chester County. As a result, the company will create 225 new full-time jobs between the Jersey Shore and Exton sites and retain 1,385 existing jobs statewide.
“We are excited to continue our growth in Lycoming County, which will help support our mission to improve the lives of patients around the world. I’m proud of our team members and they work hard every day,” said Gabe Hansen, site manager at the West Jersey Shore facility. “West has been a longtime partner in this community, and we look forward to being able to provide more employment opportunities following this expansion and are excited to help contribute to a bright and continued future for Lycoming County.
The company received a funding proposal from the Department of Community and Economic Development (DCED) for a $1.125 million grant to Pennsylvania First, a $250,000 workforce development grant to train its new workers and was encouraged to apply for the Ministry’s Manufacturing Tax Credit (MTC) and Qualified Manufacturing Innovation and Reinvestment Allowance (QMIRD) programs. West has pledged to invest $60 million in the project, create 225 new full-time jobs and retain 1,385 existing jobs over the next five years.
This project was coordinated by the Governor’s Action Team, an experienced group of economic development professionals who report directly to the Governor and work with businesses considering locating or expanding in Pennsylvania.
This is the second GAT project for West Pharmaceutical Services under the Wolf government. In September 2021, the Governor announced that the company was creating nearly 700 new jobs in western Pennsylvania.
Through GAT, Governor Wolf has invested more than $17 billion over the past seven years to support 420 completed projects, create more than 47,000 new jobs, and retain more than 143,000 jobs for Pennsylvanians.
“The Williamsport/Lycoming Chamber of Commerce is thrilled for the Jersey Shore community given West Pharmaceuticals’ announcement to expand its Jersey Shore facility. This expansion involves an investment of approximately $65 million in the local plant and will add another 125 family jobs to it,” said Jason Fink, President and CEO of the Williamsport/Lycoming Chamber of Commerce. “Thank you West for continuing to recognize the quality workforce found here in Lycoming County. We would also like to thank the local elected officials of the Jersey Shore Borough, the Jersey Shore Area School Board and the Lycoming County Board of Commissioners for their support of LERTA who played a key role in bringing this project to our region. Thank you also to the Governor’s Action Team in their efforts to win jobs in Pennsylvania and continue to partner with us in growing our economy.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high quality injectable solutions and services. As a trusted partner of established and emerging drug developers, West helps ensure the safe and effective containment and delivery of life-saving, life-enhancing drugs to patients. Founded in Pennsylvania in 1923, the company has approximately 10,000 team members in 50 locations worldwide and helps customers deliver more than 45 billion components and devices each year.
For more information on the Governor’s Action Team or the Department of Community and Economic Development, visit the DCED website.